How Trump's cannabis reclassification move could impact research

The Trump administration this week took steps to potentially reclassify cannabis as a less dangerous drug. Dr. Sue Sisley, an internal medicine clinician and principal investigator at the Scottsdale Research Institute in Arizona, joins CBS News to discuss.